Biomedal

Nos complace anunciar que Biomedal está participando activamente en la presentación de nuevas e innovadoras herramientas en el estudio de la permeabilidad intestinal, aplicado al manejo clínico del Síndrome del Intestino Irritable (SII). Nuestro CEO, Angel Cebolla Ramirez, lidera este esfuerzo, destacando nuestro compromiso con la innovación y el avance en el campo de la salud gastrointestinal. Os esperamos hoy a las 16:00!

Excited to announce our new partnership with Scientist.com! As providers on their research platform, we join industry leaders in facilitating connections between pharmaceutical, and biotech companies and top research institutions worldwide. Together, we're committed to accelerating research processes and delivering innovative solutions to the industry, scientific and clinical centers. Thrilled to be part of this platform and eager to continue providing world-class quality solutions!

Excited to announce our new partnership with Scientist.com! As providers on their research platform, we join industry leaders in facilitating connections between pharmaceutical, and biotech companies and top research institutions worldwide. Together, we're committed to accelerating research processes and delivering innovative solutions to the industry, scientific and clinical centers. Thrilled to be part of this platform and eager to continue providing world-class quality solutions!

Desde Biomedal, nos complace compartir la excelente noticia de la reciente obtención del Doctorado (Modalidad Industrial) por parte de nuestra compañera, Irati Mendia, Responsable de Proyecto e Investigadora Senior. La lectura de su Tesis Doctoral, que tuvo lugar el pasado lunes 4 de diciembre, marcó un hito significativo en su destacada carrera profesional. Queremos expresar nuestras más sinceras felicitaciones a Irati por su dedicación, esfuerzo y arduo trabajo que han culminado en este merecido logro. ¡Felicidades Irati! 😊

We are pleased to share that our latest publication "Rapid Anti-tTG-IgA Screening Test for Early Diagnosis of Celiac Disease in Pediatric Populations" of CELISIN project in Nutrients MDPI. Celiac disease is a highly underdiagnosed condition since there are many individuals in the population who do not meet the criteria for conventional diagnosis. This study explores identifying celiac disease in the pediatric population that has not yet received a diagnosis, using anti-tissue transglutaminase IgA antibody lateral flow immunoassays (anti-tTG-IgA LFIA). Check the full article here: https://lnkd.in/dUap7ueu #celiacdisease #Biomedal